W. Bauer
-
- Growth Hormone and Insulin-like Growth Factors 4
-
- Neuropeptides and Animal Physiology 3
- Epidemiology top 5%
- Neuroendocrine Tumor Research Advances 7
- Neurology top 5%
- Oncology top 10%
-
- Glycosylation and Glycoproteins Research 4
- Chemical Synthesis and Analysis 4
- Receptor Mechanisms and Signaling 3
-
- Antibiotics Pharmacokinetics and Efficacy 2
-
- Monoclonal and Polyclonal Antibodies Research 2
W. Bauer
14 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Endocrinology, Diabetes and Metabolism 433
- Cellular and Molecular Neuroscience 398
- Epidemiology 747
- Neurology 241
- Oncology 387
Countries citing papers authored by W. Bauer
This map shows the geographic impact of W. Bauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Bauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Bauer more than expected).
Fields of papers citing papers by W. Bauer
This network shows the impact of papers produced by W. Bauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Bauer. The network helps show where W. Bauer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside W. Bauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 2 | |
| 2 | 2006 | 5 | |
| 3 | 2004 | 5 | |
| 4 | 2003 | 99 | |
| 5 | 1996 | 24 | |
| 6 | 1993 | 63 | |
| 7 | 1988 | 12 | |
| 8 | 1986 | 126 | |
| 9 | SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionbreakdown → | 1982 | 1060 |
| 10 | [Pharmacokinetic studies on broad spectrum antibiotic combinations of penicillin and oxacillin in normal volunteers (author's transl)]. | 1979 | 3 |
| 11 | 1979 | 38 | |
| 12 | [Pharmacokinetic studies with a combination of mezlocillin-oxacillin]. | 1979 | 2 |
| 13 | 1977 | 297 | |
| 14 | 1977 | 6 | |
| 15 | 1956 | 1 |
About W. Bauer
W. Bauer is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology, Cellular and Molecular Neuroscience, Clinical Biochemistry and Molecular Biology, having authored 15 papers that have together received 1.7k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (7 papers), Glycosylation and Glycoproteins Research (4 papers), Chemical Synthesis and Analysis (4 papers), Growth Hormone and Insulin-like Growth Factors (4 papers), Receptor Mechanisms and Signaling (3 papers), Neuropeptides and Animal Physiology (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (433 citations), Cellular and Molecular Neuroscience (398 citations), Epidemiology (747 citations), Neurology (241 citations) and Oncology (387 citations). W. Bauer has collaborated with scholars based in Switzerland, Japan and Netherlands. Frequent co-authors include Janos Pless, R Huguenin, U. Briner, Peter Marbach, Trevor J. Petcher, W. Doepfner, Ronald C. Hill, Daniel Hauser, Annemarie Closse and D. Roemer. Their work appears in journals such as Life Sciences, Helvetica Chimica Acta, CHIMIA International Journal for Chemistry, Nature and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.